caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1891730412

Anthony El-KhoueiryM.D.

Medical OncologyLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Anthony El-Khoueiry's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 15 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Phillip Cheng
Diagnostic Radiology · Los Angeles, CA
53213
Karen Julien
Nurse Practitioner · Los Angeles, CA
45397
Suzanne Palmer
Diagnostic Radiology · West Hollywood, CA
2290
Kevin King
Diagnostic Radiology · Los Angeles, CA
21120
Bonnie Garon
Diagnostic Radiology · Los Angeles, CA
1945
LIN, LEAH1960
Mittul Gulati
Diagnostic Radiology · Los Angeles, CA
1854
WHANG, GILBERT1878
Unilab Corporation
Clinical Laboratory · West Hills, CA
14105
Miriam Romero
Diagnostic Radiology · Los Angeles, CA
1456
TEJURA, TAPAS1448
Ana Maliglig
Diagnostic Radiology · New Orleans, LA
1347
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
132
Unique beneficiaries
—
Total services
293
Distinct HCPCS
4
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 268 Medical Oncology providers in CA — bottom quintile (cohort median 1,130).
PRESCRIBING · PART D · 2024
Total Rx claims
14
Beneficiaries
—
Total drug cost
$134
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Ondansetron Hcl/Pf14 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$30K
Payment records
18
By payment type
Consulting Fee$29K
Food and Beverage$982
Travel and Lodging$320